ScienceET Techabout 2 hours ago
Molbio Diagnostics IPO Targets ₹940 Crore Raise
2 min read
Molbio Diagnostics plans a ₹200 crore fresh issue for capital expenditure and a ₹740 crore offer for sale. The promoter stake will drop to 43% from 46.6%. The company operates six Indian facilities, serving 90+ countries, but top clients drive over half of revenue.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
